Abstract
TFE3-splicing factor fusions possess both transcription and splicing factor functions that remodel the transcriptome and spliceosome and can be targeted with dimerization inhibitors to suppress the growth of translocation renal cell carcinoma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have